(CG) Carlyle - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14316J1088

PrivateEquity, RealAssets, GlobalMarkets, InvestmentFunds

CG EPS (Earnings per Share)

EPS (Earnings per Share) of CG over the last years for every Quarter: "2020-03": -1.7574096929759, "2020-06": 0.40837656181643, "2020-09": 0.82448442519624, "2020-12": 1.4423130386433, "2021-03": 2.4113409863059, "2021-06": 2.5541789681448, "2021-09": 1.4607637699878, "2021-12": 1.8211565750333, "2022-03": 1.5746109683389, "2022-06": 0.66992108908313, "2022-09": 0.76556672794654, "2022-12": 0.34697217675941, "2023-03": 0.27562022762344, "2023-06": -0.27237751523612, "2023-09": 0.22356317350812, "2023-12": -1.9179600886918, "2024-03": 0.1776123912801, "2024-06": 0.40392917884087, "2024-09": 1.6300001012422, "2024-12": 0.56861687786465, "2025-03": 0.3548646068687, "2025-06": 0.87111716621253,

CG Revenue

Revenue of CG over the last years for every Quarter: 2020-03: -416.3, 2020-06: 645.7, 2020-09: 807.9, 2020-12: 1096.9, 2021-03: 1582.9, 2021-06: 1709.7, 2021-09: 1144.2, 2021-12: 1386.8, 2022-03: 1213.9, 2022-06: 818.5, 2022-09: 894.7, 2022-12: 647.3, 2023-03: 756.9, 2023-06: 569.9, 2023-09: 761.2, 2023-12: -220.9, 2024-03: 754.2, 2024-06: 920.4, 2024-09: 1486.7, 2024-12: 927, 2025-03: 807.8, 2025-06: 1619.7,

Description: CG Carlyle

The Carlyle Group Inc. is a diversified investment firm with a broad range of investment strategies across four main segments: Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firms investments span multiple industries, including industrial, consumer, aerospace, defense, technology, and financial services, among others.

From a business perspective, Carlyles strength lies in its ability to invest across various asset classes and industries, providing a diversified revenue stream. Key Performance Indicators (KPIs) to monitor include Assets Under Management (AUM), investment performance, and fundraising success. As of the latest available data, Carlyles AUM is a key metric to track the firms growth and scale.

In terms of financial performance, Carlyles revenue is driven by management fees, performance fees, and investment income. Key metrics to evaluate include revenue growth, margin expansion, and return on equity (RoE). With a reported RoE of 18.58%, Carlyle demonstrates a strong ability to generate returns for shareholders.

To further assess Carlyles investment performance, its essential to examine the firms investment portfolio, including the types of investments made, industry allocation, and geographic distribution. Additionally, monitoring the firms fundraising activities, including the size and frequency of new funds, can provide insights into its ability to attract capital from investors.

From a valuation perspective, Carlyles stock trades at a P/E ratio of 19.90, with a forward P/E of 14.58, indicating a relatively attractive valuation compared to peers. The firms market capitalization stands at $21.7 billion, reflecting its size and market presence.

CG Stock Overview

Market Cap in USD 23,305m
Sub-Industry Asset Management & Custody Banks
IPO / Inception 2012-05-03

CG Stock Ratings

Growth Rating 68.9%
Fundamental 57.8%
Dividend Rating 66.3%
Return 12m vs S&P 500 40.8%
Analyst Rating 3.56 of 5

CG Dividends

Dividend Yield 12m 2.42%
Yield on Cost 5y 6.44%
Annual Growth 5y 6.96%
Payout Consistency 89.9%
Payout Ratio 35.7%

CG Growth Ratios

Growth Correlation 3m 94.2%
Growth Correlation 12m 35.6%
Growth Correlation 5y 48.3%
CAGR 5y 34.23%
CAGR/Max DD 3y 0.89
CAGR/Mean DD 3y 3.73
Sharpe Ratio 12m 1.78
Alpha 65.23
Beta 0.671
Volatility 35.23%
Current Volume 1402.2k
Average Volume 20d 2276.9k
Stop Loss 64.4 (-3.3%)
Signal -0.33

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (1.26b TTM) > 0 and > 6% of Revenue (6% = 290.5m TTM)
FCFTA 0.04 (>2.0%) and ΔFCFTA 2.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -91.18% (prev -106.3%; Δ 15.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.04 (>3.0%) and CFO 969.3m <= Net Income 1.26b (YES >=105%, WARN >=100%)
Net Debt (8.97b) to EBITDA (1.85b) ratio: 4.86 <= 3.0 (WARN <= 3.5)
Current Ratio 0.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (367.0m) change vs 12m ago 0.03% (target <= -2.0% for YES)
Gross Margin 76.94% (prev 71.80%; Δ 5.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 20.45% (prev 9.94%; Δ 10.51pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 2.46 (EBITDA TTM 1.85b / Interest Expense TTM 688.1m) >= 6 (WARN >= 3)

Altman Z'' -0.31

(A) -0.18 = (Total Current Assets 2.07b - Total Current Liabilities 6.49b) / Total Assets 25.07b
(B) 0.08 = Retained Earnings (Balance) 1.95b / Total Assets 25.07b
(C) 0.07 = EBIT TTM 1.69b / Avg Total Assets 23.68b
(D) 0.11 = Book Value of Equity 1.95b / Total Liabilities 18.35b
Total Rating: -0.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 57.75

1. Piotroski 3.0pt = -2.0
2. FCF Yield 1.98% = 0.99
3. FCF Margin 18.37% = 4.59
4. Debt/Equity 3.46 = -1.42
5. Debt/Ebitda 12.59 = -2.50
6. ROIC - WACC 4.18% = 5.23
7. RoE 21.43% = 1.79
8. Rev. Trend 9.22% = 0.46
9. Rev. CAGR 0.0% = 0.0
10. EPS Trend 24.45% = 0.61
11. EPS CAGR 0.0% = 0.0

What is the price of CG shares?

As of September 15, 2025, the stock is trading at USD 66.60 with a total of 1,402,247 shares traded.
Over the past week, the price has changed by +3.82%, over one month by +3.17%, over three months by +42.36% and over the past year by +66.50%.

Is Carlyle a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Carlyle is currently (September 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 57.75 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CG is around 74.39 USD . This means that CG is currently undervalued and has a potential upside of +11.7% (Margin of Safety).

Is CG a buy, sell or hold?

Carlyle has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold CG.
  • Strong Buy: 4
  • Buy: 3
  • Hold: 10
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the CG price?

Issuer Target Up/Down from current
Wallstreet Target Price 68.1 2.2%
Analysts Target Price 68.1 2.2%
ValueRay Target Price 80 20.2%

Last update: 2025-09-04 04:34

CG Fundamental Data Overview

Market Cap USD = 23.30b (23.30b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 1.74b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 18.8392
P/E Forward = 13.21
P/S = 4.2176
P/B = 3.9766
P/EG = 1.2421
Beta = 1.888
Revenue TTM = 4.84b USD
EBIT TTM = 1.69b USD
EBITDA TTM = 1.85b USD
Long Term Debt = 16.76b USD (from nonCurrentLiabilitiesTotal, last fiscal year)
Short Term Debt = 6.49b USD (from totalCurrentLiabilities, last quarter)
Debt = 23.24b USD (Calculated: Short Term 6.49b + Long Term 16.76b)
Net Debt = 8.97b USD (from netDebt column, last quarter)
Enterprise Value = 44.81b USD (23.30b + Debt 23.24b - CCE 1.74b)
Interest Coverage Ratio = 2.46 (Ebit TTM 1.69b / Interest Expense TTM 688.1m)
FCF Yield = 1.98% (FCF TTM 889.3m / Enterprise Value 44.81b)
FCF Margin = 18.37% (FCF TTM 889.3m / Revenue TTM 4.84b)
Net Margin = 25.95% (Net Income TTM 1.26b / Revenue TTM 4.84b)
Gross Margin = 76.94% ((Revenue TTM 4.84b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Tobins Q-Ratio = 22.98 (Enterprise Value 44.81b / Book Value Of Equity 1.95b)
Interest Expense / Debt = 0.86% (Interest Expense 198.8m / Debt 23.24b)
Taxrate = 21.71% (302.6m / 1.39b)
NOPAT = 1.33b (EBIT 1.69b * (1 - 21.71%))
Current Ratio = 0.32 (Total Current Assets 2.07b / Total Current Liabilities 6.49b)
Debt / Equity = 3.46 (Debt 23.24b / last Quarter total Stockholder Equity 6.72b)
Debt / EBITDA = 12.59 (Net Debt 8.97b / EBITDA 1.85b)
Debt / FCF = 26.13 (Debt 23.24b / FCF TTM 889.3m)
Total Stockholder Equity = 5.86b (last 4 quarters mean)
RoA = 5.01% (Net Income 1.26b, Total Assets 25.07b )
RoE = 21.43% (Net Income TTM 1.26b / Total Stockholder Equity 5.86b)
RoCE = 7.49% (Ebit 1.69b / (Equity 5.86b + L.T.Debt 16.76b))
RoIC = 8.77% (NOPAT 1.33b / Invested Capital 15.13b)
WACC = 4.59% (E(23.30b)/V(46.55b) * Re(8.49%)) + (D(23.24b)/V(46.55b) * Rd(0.86%) * (1-Tc(0.22)))
Shares Correlation 3-Years: 21.21 | Cagr: 0.01%
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 68.46% ; FCFE base≈588.9m ; Y1≈386.6m ; Y5≈176.8m
Fair Price DCF = 8.91 (DCF Value 3.22b / Shares Outstanding 361.7m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 9.22 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: 102.4
EPS Correlation: 24.45 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 156.9

Additional Sources for CG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle